The SUMO E2 conjugating enzyme (also called UBC9) is a widely studied protein in neoplasm and has been found upregulated in many solid tumors, including breast cancer, lung adenocarcinoma, liver cancer, and prostate cancer [14,15,16]. Here, UBE2I is linked to prostate carcinoma.